These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 417232)

  • 41. Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment.
    Gaman W; Cates C; Snelling CF; Lank B; Ronald AR
    Antimicrob Agents Chemother; 1976 Mar; 9(3):474-80. PubMed ID: 816250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pyocin typing of Pseudomonas aeruginosa strains isolated from various sources].
    Kantarci G
    Mikrobiyol Bul; 1992 Jan; 26(1):17-25. PubMed ID: 1574018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tobramycin: comparison with gentamicin and carbenicillin in regard to 200 serotyped strains of Pseudomonas aeruginosa].
    Turgeon PL
    Union Med Can; 1977 Jan; 106(1):46-50. PubMed ID: 403645
    [No Abstract]   [Full Text] [Related]  

  • 44. Carbenicillin and gentamicin in the treatment of Pseudomonas aeruginosa infection.
    Yuce K; Van Rooyen CE
    Can Med Assoc J; 1971 Nov; 105(9):919-22. PubMed ID: 5004774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pyocin production by bacillus pyocyaneus and sensitivity of strains of different origin to them].
    Kurnosova LM; Sukhodol'skaia AE; Suvorova TI; Faustova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):8-13. PubMed ID: 6776722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro experiments on the working of combinations of gentamicin and beta-lactam antibiotics against Pseudonomas aeruginosa (author's transl)].
    Ullmann U
    Immun Infekt; 1975 Apr; 3(2):79-85. PubMed ID: 810407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bacteriostatic activity of azlocillin, gentamycin, amikacin singly or in combination on 200 strains of Pseudomonas aeruginosa].
    Texier-Maugein J; Fourche J; Mormede M; Mazaud C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):415-8. PubMed ID: 3095774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gentamicin- and silver-resistant pseudomonas in a burns unit.
    Bridges K; Kidson A; Lowbury EJ; Wilkins MD
    Br Med J; 1979 Feb; 1(6161):446-9. PubMed ID: 106914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antibiotic associations on acting Pseudomonas aeruginosa].
    Duval J; Mathieu-Saint-Laurent P; Soussy CL
    Pathol Biol (Paris); 1971; 19(11):637-48. PubMed ID: 4997792
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin.
    Phair JP; Watanakunakorn C; Bannister T
    Appl Microbiol; 1969 Sep; 18(3):303-6. PubMed ID: 4984762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Importance of carbenicillin and gentamicin cross-resistant serotype 0:12 Pseudomonas aeruginosa in six Athens hospitals.
    Legakis NJ; Koukoubanis N; Malliara K; Michalitsianos D; Papavassiliou J
    Eur J Clin Microbiol; 1987 Jun; 6(3):300-3. PubMed ID: 3113940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Typing of pseudomonas aeruginosa by pyocine production. Experiments with a simplified method using four indicator strains (author's transl)].
    Küchler R
    Zentralbl Bakteriol Orig A; 1975; 230(2):192-202. PubMed ID: 807054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pseudomonas aeruginosa R factors determining gentamicin plus carbenicillin resistance from patients with urinary tract colonizations.
    Korfhagen TR; Loper JC; Ferrel JA
    Antimicrob Agents Chemother; 1975 Jan; 7(1):64-8. PubMed ID: 806258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outer surface changes of Pseudomonas aeruginosa in relation to resistance to gentamicin and carbenicillin.
    Katsorchis T; Legakis NJ; Shearer B; Genmmata V; Pataryas H
    J Med Microbiol; 1985 Jun; 19(3):375-81. PubMed ID: 2989527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunotyping and pyocin typing of Pseudomonas aeruginosa from clinical specimens.
    Kurup VP; Sheth NK
    Am J Clin Pathol; 1976 Apr; 65(4):557-63. PubMed ID: 817593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the in vitro activity of BL-P1654 with gentamicin and carbenicillin against Pseudomonas aeruginosa.
    Watanakunakorn C; Bannister T
    Antimicrob Agents Chemother; 1974 Oct; 6(4):471-3. PubMed ID: 4157347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.
    Lopez CE; Standiford HC; Tatem BA; Calia FM; Schimpff SC; Snyder MJ; Hornick RB
    Antimicrob Agents Chemother; 1977 Mar; 11(3):441-8. PubMed ID: 404963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Production of pyocins and their use in the typing of Pseudomonas aeruginosa].
    Wilhelms D
    Z Gesamte Hyg; 1977 Sep; 23(9):672-5. PubMed ID: 412335
    [No Abstract]   [Full Text] [Related]  

  • 59. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.
    Duncan IB
    Antimicrob Agents Chemother; 1974 Jan; 5(1):9-15. PubMed ID: 4365116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nosocomial infection with gentamicin-carbenicillin-resistant Pseudomonas aeruginosa.
    Baird IM; Slepack JM; Kauffman CA; Phair JP
    Antimicrob Agents Chemother; 1976 Oct; 10(4):626-9. PubMed ID: 825033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.